Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1647 studies found for:    bone AND (woman OR women OR female)
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Study Comparing Bone Loss in Women Who Take Calcium and Vitamin D With Women Who Also Take Risedronate or Exercise
Condition: Osteopenia.
Interventions: Drug: Calcium carbonate;   Drug: Vitamin D3;   Drug: Risedronate;   Behavioral: Bone-loading exercises
2 Recruiting Creatine on Bone Mass in Postmenopausal Women
Condition: Postmenopausal Women
Interventions: Dietary Supplement: Creatine supplementation;   Dietary Supplement: dextrose (placebo)
3 Completed Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
Conditions: Breast Cancer;   Osteoporosis
Intervention: Other: Bone Mineral Density
4 Completed
Has Results
A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer
Condition: Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women.
Interventions: Drug: Letrozole;   Drug: Tamoxifen
5 Recruiting Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly
Condition: Alveolar Bone Healing After Dental Extraction
Intervention: Procedure: Dental extraction
6 Completed Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy
Conditions: Menopause;   Postmenopausal Bone Loss;   Breast Cancer
Intervention: Drug: Tibolone
7 Completed
Has Results
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
Conditions: Breast Neoplasms;   Osteoporosis
Interventions: Drug: Zoledronic Acid;   Drug: Letrozole
8 Completed Bone Microarchitecture in Women With and Without Fracture
Conditions: Osteoporosis;   Fracture
Intervention:
9 Completed The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause
Conditions: Bone Density;   Osteopenia;   Osteoporosis;   Post-Menopause
Intervention: Device: Juvent 1000 Dynamic Motion Therapy (DMT) Platform
10 Completed Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause
Condition: Perimenopausal Bone Loss
Interventions: Drug: Natto capsules (food suppl.) cont. 360 microg. vit K2/day;   Drug: Placebo capsules
11 Active, not recruiting Longitudinal Lactation Bone Density Study
Conditions: Lactation;   Other Disorders of Bone Density and Structure;   Endocrine; Complications
Intervention:
12 Completed Effects of Arzoxifene on Bone Mass and the Uterus
Condition: Postmenopausal Bone Loss
Interventions: Drug: Arzoxifene;   Drug: Placebo
13 Completed
Has Results
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
Conditions: Low Bone Mass;   Low Bone Mineral Density;   Osteoporosis;   Postmenopausal Osteoporosis
Intervention: Drug: Previous denosumab
14 Completed
Has Results
Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density
Condition: Osteoporosis
Interventions: Drug: Raloxifene;   Drug: Zoledronic acid;   Drug: Placebo oral pills;   Drug: Placebo intravenous (i.v.) infusion
15 Terminated
Has Results
A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss
Condition: Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women
Interventions: Drug: Zoledronic Acid;   Drug: Placebo
16 Completed Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation Study
Condition: Bone Diseases, Endocrine
Intervention:
17 Completed African-American Bone Metabolism and Lactation Study
Conditions: Lactation;   Bone Diseases, Endocrine
Intervention:
18 Completed
Has Results
Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
Condition: Osteoporosis
Interventions: Drug: Full Length Parathyroid Hormone, PTH(1-84);   Drug: Strontium Ranelate
19 Completed
Has Results
A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females
Condition: Bone Mineral Density
Interventions: Drug: 91-day Levonorgestrel Oral Contraceptive;   Drug: 28-day Levonorgestrel Oral Contraceptive
20 Completed
Has Results
The Effect of Protein Supplementation on Bone Health in Healthy Older Men and Women
Conditions: Bone Resorption;   Osteoporosis
Interventions: Dietary Supplement: Whey protein supplement;   Dietary Supplement: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years